IPSC/Induced Pluripotent Stem Cell Market Segmentation – Hepatocytes, Fibroblasts, Keratinocytes And Amniotic Cells Analysis

IPSC/Induced Pluripotent Stem Cell Market Segmentation - Hepatocytes, Fibroblasts, Keratinocytes And Amniotic Cells Analysis

“Induced Pluripotent Stem Cell (IPSC) Global Market Report 2019”
Takara Bio Inc. Is One Of The Largest Companies In The Induced Pluripotent Stem Cell (iPSC) Market, According To TBRC’s Report
(Companies: Thermo Fisher Scientific Inc., FUJIFILM Holdings Corporation (Cellular Dynamics), Takara Bio Inc., Astellas Pharma Inc. and Fate Therapeutics)

Take a look at our year-end deals on Opportunities and Strategies Reports! Up to 50% off on all licenses.

https://www.thebusinessresearchcompany.com/discounted-reports.aspx

The global induced pluripotent stem cell (iPSC) market was valued at about $1.98 billion in 2018. The induced pluripotent stem cell (iPSC) market consists of sales of induced pluripotent stem cells and related services. Induced pluripotent stem cells are the regenerated form of stem cells, which are produced from an existing adult cell, such as hepatocytes, fibroblasts, keratinocytes and neurons.

View complete report @ https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-ipsc-global-market-report

The global induced pluripotent stem cell (iPSC) market is expected to grow to $2.82 billion at a rate of about 9.2% through 2022. Chronic disorders like heart disease, cancer, stroke, diabetes can be treated with induced pluripotent stem cell. The rise in incidences of chronic diseases is driving the demand for induced pluripotent stem cell treatment. The potential risk of tumors is one of the major restraints on the growth of induced pluripotent stem cell market.

Companies in the induced pluripotent stem cell market are looking for opportunities for strategic partnerships and collaborations that will help these companies to enter into new geographies and to expand product portfolios. For example, in January 2017, Fujifilm made a strategic collaboration with Cynata for development and commercialization CYP-001 for graft-versus-host disease (GVHD). Under this agreement, Fujifilm took a strategic equity stake in Cynata Therapeutics of 9%, for which they paid $3.97 million.

Major players in the market are Thermo Fisher Scientific Inc., FUJIFILM Holdings Corporation (Cellular Dynamics), Takara Bio Inc., Astellas Pharma Inc. and Fate Therapeutics. Takara Bio Inc. is an innovative biotechnology company based in Shiga, Japan.

Request A Sample Of The Global Induced Pluripotent Stem Cell (iPSC) Market Report https://www.thebusinessresearchcompany.com/sample.aspx?id=2515&type=smp

Few Points From Table Of Contents: 

2. Induced Pluripotent Stem Cell Market Market Characteristics

3. Induced Pluripotent Stem Cell Market Market Size And Growth

3.1. Global Induced Pluripotent Stem Cell Market Historic Market, 2014 – 2018, $ Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Induced Pluripotent Stem Cell Market Forecast Market, 2018 – 2022F, 2025F, 2030F, $ Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Induced Pluripotent Stem Cell Market Market Segmentation

4.1. Global Induced Pluripotent Stem Cell Market Market, Segmentation By Derived Cell Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Hepatocytes

Fibroblasts

Keratinocytes

Amniotic Cells

Others

4.2. Global Induced Pluripotent Stem Cell Market Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Academic Research

Drug Development And Discovery

Toxicity Screening

Regenerative Medicine

4.3. Global Induced Pluripotent Stem Cell Market Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Hospitals

Research Laboratories

5. Induced Pluripotent Stem Cell Market Market Regional And Country Analysis

5.1. Global Induced Pluripotent Stem Cell Market Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Place a Direct Purchase Order @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2515

About The Business Research Company

The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Media Contact
Company Name: The Business Research Company
Contact Person: Nitin
Email: Send Email
Phone: 08897263534
Address:1st Floor, Anshu Colors Building, Road Number 1 Park View Enclave, Jubilee Hills
City: Hyderabad 500033
State: Telengana
Country: India
Website: https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-ipsc-global-market-report